Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




High Levels of Cardiac Hormone Predict Heart Risks

By HospiMedica staff writers
Posted on 17 Oct 2001
A study has found that elevated levels of a cardiac hormone called B-type natriuretic peptide (BNP) are predictive of an increased risk of death or heart failure in patients experiencing complications of coronary artery disease. More...
Conducted by researchers at the University of Texas Southwestern Medical Center (Dallas, USA) and Brigham and Women's Hospital in Boston (MA, USA), the study was published in the October 4, 2001, issue of The New England Journal of Medicine.

The study assessed the levels of BNP in 2,525 patients following hospital admission for acute coronary syndromes (ACS). The researchers found that BNP levels proved to be better at predicting adverse outcomes from heart attacks than traditional methods, even up to 10 months after admission. The study involved patients from a landmark Thrombolysis in Myocardial Infarction (TIMI) study. The BNP test used in the study was the Triage BNP test from Biosite Inc. (San Diego, CA, USA). The test measures the circulating levels of BNP.

A clinical trial under way is designed to determine the clinical utility of the Triage BNP test in assessing the effectiveness of therapy in patients with congestive heart failure. Biosite hopes to use data from this study to expand its product claims for the test.



Related Links:
www.biosite.com

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.